Dr Scott R Cooper, MD | |
1275 Elm St, West Springfield, MA 01089-1820 | |
(413) 785-1153 | |
(413) 781-4951 |
Full Name | Dr Scott R Cooper |
---|---|
Gender | Male |
Speciality | Physical Medicine And Rehabilitation |
Experience | 36 Years |
Location | 1275 Elm St, West Springfield, Massachusetts |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235175530 | NPI | - | NPPES |
11538 | Other | MA | HEALTH NEW ENGLAND |
80222 | Other | MA | HARVARD PILGRIM |
3094596 | Medicaid | MA | |
J12589 | Other | MA | BCBS |
755362 | Other | MA | TUFTS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 75800 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Cooley Dickinson Hospital Inc,the | Northampton, MA | Hospital |
Baystate Medical Center | Springfield, MA | Hospital |
Holyoke Medical Center | Holyoke, MA | Hospital |
Baystate Noble Hospital | Westfield, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Pioneer Spine And Sports Physicians Pc | 5991609174 | 30 |
News Archive
Companion test also approved to identify appropriate patients The U.S. Food and Drug Administration today approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test. Lung cancer is the leading cause of cancer-related death among men and women.
A new study finds gender differences in parenting and household labor persist among a group of highly motivated physician-researchers in the early stages of their career.
Researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and the University of Massachusetts Medical School have developed a strategy to treat two of the most common inherited blood diseases - sickle cell disease and beta thalassemia - applying CRISPR-Cas9 gene editing to patients' own blood stem cells.
Mycobacterium ulcerans infects the skin and subcutaneous tissues and secretes a lipid toxin, mycolactone, which causes open skin lesions, known as Buruli ulcers.
› Verified 2 days ago
Entity Name | Pioneer Spine And Sports Physicians Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346282621 PECOS PAC ID: 5991609174 Enrollment ID: O20060712000051 |
News Archive
Companion test also approved to identify appropriate patients The U.S. Food and Drug Administration today approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test. Lung cancer is the leading cause of cancer-related death among men and women.
A new study finds gender differences in parenting and household labor persist among a group of highly motivated physician-researchers in the early stages of their career.
Researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and the University of Massachusetts Medical School have developed a strategy to treat two of the most common inherited blood diseases - sickle cell disease and beta thalassemia - applying CRISPR-Cas9 gene editing to patients' own blood stem cells.
Mycobacterium ulcerans infects the skin and subcutaneous tissues and secretes a lipid toxin, mycolactone, which causes open skin lesions, known as Buruli ulcers.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Scott R Cooper, MD 1275 Elm St, West Springfield, MA 01089-1820 Ph: (413) 785-1153 | Dr Scott R Cooper, MD 1275 Elm St, West Springfield, MA 01089-1820 Ph: (413) 785-1153 |
News Archive
Companion test also approved to identify appropriate patients The U.S. Food and Drug Administration today approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test. Lung cancer is the leading cause of cancer-related death among men and women.
A new study finds gender differences in parenting and household labor persist among a group of highly motivated physician-researchers in the early stages of their career.
Researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and the University of Massachusetts Medical School have developed a strategy to treat two of the most common inherited blood diseases - sickle cell disease and beta thalassemia - applying CRISPR-Cas9 gene editing to patients' own blood stem cells.
Mycobacterium ulcerans infects the skin and subcutaneous tissues and secretes a lipid toxin, mycolactone, which causes open skin lesions, known as Buruli ulcers.
› Verified 2 days ago
Dr. Douglas R Molin, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 271 Park Street, West Springfield, MA 01089 Phone: 413-785-1153 | |
Gregory B Park, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 271 Park St, West Springfield, MA 01089 Phone: 413-785-1153 | |
Dr. Derek C Davidson, D.O., MSPT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 271 Park St, West Springfield, MA 01089 Phone: 413-785-1153 | |
Phong Nguyen Kieu, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 271 Park St, West Springfield, MA 01089 Phone: 413-785-1183 | |
David A Bowers, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1275 Elm St, West Springfield, MA 01089 Phone: 413-785-1153 Fax: 413-781-4951 | |
Sarah Sarita Narayan, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 271 Park St, West Springfield, MA 01089 Phone: 413-785-1153 |